| dc.contributor.author | Burton, M.J. | |
| dc.contributor.author | Clarkson, Janet E. | |
| dc.contributor.author | Goulao, Beatriz | |
| dc.contributor.author | Glenny, Anne-Marie | |
| dc.contributor.author | McBain, Andrew J. | |
| dc.contributor.author | Schilder, Anne G.M. | |
| dc.contributor.author | Webster, Katie E. | |
| dc.contributor.author | Worthington, Helen V | |
| dc.date.accessioned | 2021-09-15T23:11:09Z | |
| dc.date.available | 2021-09-15T23:11:09Z | |
| dc.date.issued | 2020-09-16 | |
| dc.identifier | 176455402 | |
| dc.identifier | d787739a-b952-4c96-95cc-a23eb53d3a3d | |
| dc.identifier | 85085094740 | |
| dc.identifier | 000579343700008 | |
| dc.identifier.citation | Burton , M J , Clarkson , J E , Goulao , B , Glenny , A-M , McBain , A J , Schilder , A G M , Webster , K E & Worthington , H V 2020 , ' Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them (Review) ' , Cochrane Database of Systematic Reviews , vol. 2020 , no. 9 , CD013627 . https://doi.org/10.1002/14651858.CD013627.pub2 | en |
| dc.identifier.issn | 1469-493X | |
| dc.identifier.uri | https://hdl.handle.net/2164/17083 | |
| dc.description | A C K N O W L E D G E M E N T S: We would like to thank the peer reviewers, Professor Jeremy Bagg, Dr Karolin Hijazi, Professor Carl Philpott and Professor Claire Hopkins, fortheirinsightful comments, which helped us to improve these reviews. Thanks also to Professor Peter Tugwell, Senior Editor Cochrane MOSS Network, for acting as sign-oF editor for these projects. We are also grateful to Doug Salzwedel from the Cochrane Hypertension Group for providing search peer review comments for the draK search strategy. Professor Schilder's time for this project was supported by the National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. This project was supported by the National Institute for Health Research, via Cochrane Infrastructure, Cochrane Programme Grant or Cochrane Incentive funding to Cochrane ENT and Cochrane Oral Health. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Systematic Reviews Programme, NIHR, NHS or the Department of Health. | en |
| dc.format.extent | 42 | |
| dc.format.extent | 417144 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Cochrane Database of Systematic Reviews | en |
| dc.subject | CORONAVIRUS | en |
| dc.subject | R Medicine | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject | National Institute for Health Research (NIHR) | en |
| dc.subject.lcc | R | en |
| dc.title | Antimicrobial mouthwashes (gargling) and nasal sprays administered to patients with suspected or confirmed COVID‐19 infection to improve patient outcomes and to protect healthcare workers treating them (Review) | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | 10.1002/14651858.CD013627.pub2 | |
| dc.date.embargoedUntil | 2021-09-16 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85085094740&partnerID=8YFLogxK | en |
